Oral Paclitaxel Before Surgery for Older Adults With Lung Cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether a pill form of paclitaxel (a chemotherapy drug) given before surgery can help treat non-small cell lung cancer in adults aged 70–85. The goal is to shrink the tumor before removing it surgically, which may improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 70 and 85 years old
- Your lung cancer is confirmed by biopsy and is stage IIA–IIIB (early-to-mid stage, not spread to distant organs)
- Your doctors believe your cancer can be surgically removed with intent to cure
- You have not received prior chemotherapy, radiation, or surgery for this cancer
- Your heart, liver, kidneys, and bone marrow function are adequate to tolerate chemotherapy and surgery
- You do not have active infections, autoimmune disease, or other serious health conditions that would make treatment unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two chemotherapy drugs (paclitaxel and cisplatin) plus an immunotherapy drug (cadonilimab) given before surgery for advanced esophageal cancer. The goal is to see if this treatment shrinks the tumor and improves outcomes.
This trial tests a combination of an immunotherapy drug (adebrelimab) plus chemotherapy and another drug (recaticimab) before and after surgery for people with stage II or III lung cancer that can be removed. The goal is to see if this approach helps shrink tumors and improves outcomes.
This trial tests a new way to treat non-small cell lung cancer in people aged 70 or older. You will receive oral chemotherapy (paclitaxel) with immunotherapy and focused radiation (SBRT) before surgery, hoping to shrink the tumor and improve outcomes.
This trial tests an oral form of a common chemo drug, paclitaxel, given before surgery for triple-negative breast cancer. It aims to find the best dose and see how well it shrinks tumors.
This trial tests an oral form of paclitaxel combined with standard HER2 therapy given before surgery for HER2-positive breast cancer. It aims to find the best dose and see how well it works.
This trial tests a pill form of chemotherapy (oral paclitaxel) combined with an immunotherapy drug to keep advanced lung cancer from growing after initial treatment. It may help patients whose cancer was controlled with first-line therapy.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.